SOBRsafe Receives $2.8 Million in Gross Proceeds From Exercise of Warrants, Also Fully Converts All Notes Payable Into Common Equity
SOBRsafe Receives $2.8 Million in Gross Proceeds From Exercise of Warrants, Also Fully Converts All Notes Payable Into Common Equity
The Company Strengthens Balance Sheet, Takes Strides to Regaining Nasdaq Listing Compliance
公司加強資產負債表,努力重新獲得納斯達克上市合規性。
DENVER, CO / ACCESSWIRE / June 6, 2024 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe" or "the Company"), provider of next-generation transdermal alcohol detection solutions, announced today that it has received approximately $2.8 million in gross proceeds from the exercise of Warrants. Details on the transaction are below, or view the corresponding Form 8-K.
美國科羅拉多州丹佛/ACCESSWIRE/2024年6月6日/SOBR Safe,Inc.(納斯達克:SOBR)(以下簡稱“SOBRsafe”或者“公司”)提供下一代經皮酒精檢測方案,今天宣佈已從行權證獲得大約280萬美元的毛收益。請查看交易細節或對應的8-K表。
SOBRsafe has also settled its remaining debt balances through the conversion of outstanding Notes Payable into 4,358,957 shares of Common Stock.
SOBRsafe還通過將未償還的應付票據轉換成4358957股普通股來償付其餘債務餘額。
"These are very positive developments for the future of SOBRsafe," affirmed CEO & Chairman Dave Gandini. "We have significantly strengthened our balance sheet with both this infusion of capital and elimination of $2.6 million in debt, which alleviates future cash payments. Moreover, we have increased our prospective equity balances consistent with our plan to regain the Company's Nasdaq listing compliance. We continue to build flexibility into our capital structure, and believe we are now better positioned for accelerated growth."
“這些是SOBRsafe未來非常積極的發展,”首席執行官和董事長戴夫·甘迪尼(Dave Gandini)說,“我們通過資本注入和償還260萬美元的債務,大大增強了我們的資產負債表,避免了未來的現金支付。此外,我們根據計劃增加了潛在的股權餘額,以符合公司重獲納斯達克上市合規性的計劃。我們繼續爲我們的資本結構增加靈活性,並相信我們現在處於更好的加速增長位置。”
Warrant Inducement Transaction
行權誘因交易
On June 4, 2024, the Company entered into an inducement offer letter agreement (the "Inducement Letter") with the holder (the "Holder") of the Company's warrants issued pursuant to the Amended and Restated Common Stock Purchase Warrants, with an initial exercise date of September 27, 2021, dated September 30, 2022, the Amended and Restated Common Stock Purchase Warrants, with an initial exercise date of March 30, 2022, dated September 30, 2022 and warrants issued to the Holder under the Waiver agreement dated March 30, 2022, (collectively, the "Applicable Warrants").
2024年6月4日,公司與持有公司根據修訂後的普通股認購證明,初始行權日期爲2021年9月27日,於2022年9月30日簽訂的修訂後的普通股認購證明,初始行權日期爲2022年3月30日,於2022年9月30日簽訂的豁免協議下發給的持有人的授權證明(統稱相關行權證明)的持有人(以下簡稱“持有人”)簽訂引誘報價信函協議(以下簡稱“引誘信函”)。
Pursuant to the Inducement Letter, the Holder agreed to convert all the Applicable Warrants at a reduced exercise price equal to $0.27 per share (such reduced exercise price, the "Reduced Exercise Price"). Simultaneously with the execution of the Inducement Letter, the Company received exercise notices from the Holder for the conversion of 10,319,163 of the Applicable Warrants, representing 100% of the Applicable Warrants.
根據引誘信函,持有人同意以每股0.27美元的降低行權價格將所有適用的行權證明轉換爲股票(該降低行權價格稱爲“降低行權價格”)。與簽署引誘信函同時,公司收到了持有人的行權通知,要求轉換其所有適用行權證明的10319163份,相當於適用行權證明的100%。
The shares of common stock of the Company underlying the Applicable Warrants (the "Warrant Shares") are eligible for resale pursuant to Rule 144 of the Securities Act or have been registered for resale pursuant to registration statements on Form S-1 (File No. 333-267882) (File No. 333-262665) (the "Registration Statements"). The Registration Statements are currently effective and, upon exercise of the Applicable Warrants will be effective for the resale of the Warrant Shares.
公司普通股權益下的適用行權證明(即行權股)可按照《證券法》第144規則進行轉讓,或已在S-1表格(文件號:333-267882和文件號:333-262665)中進行了註冊轉讓。註冊表格目前有效,在行使適用的行權證明後將對行使行權股票的轉讓有效。
In exchange for the transactions contemplated hereunder, the Company shall concurrently issue the Holder 20,638,326 new warrants (the "New Warrant") to subscribe for and purchase from the Company 20,638,326 shares (the "New Warrant Shares"). The New Warrant exercise price shall be $0.27 subject to adjustment thereunder.
作爲此次交易的交換,公司將同時向持有人發行20638326個新的認股權證(以下簡稱“新認股證”),以認購20638326股(以下簡稱“新認股股票”)。新認股價格爲0.27美元,根據其中的調整情況。
This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
本新聞稿不構成出售或邀請出售這些證券的要約,也不得在任何州或司法管轄區銷售這些證券,除非在任何此類州或司法管轄區根據任何這類州或司法管轄區的證券法律註冊或合格前。
---
---
About SOBRsafe
關於SOBRsafe
Alcohol misuse is the fourth leading cause of preventable death in America, and the seventh worldwide. Yet prevention and monitoring solutions have not kept pace with this epidemic. Legacy technologies are invasive and inefficient, unhygienic, and unconnected. There has to be a better way.
酗酒是美國第四大可預防死亡原因,在全球範圍內排名第七。但預防和監測解決方案沒有跟上這場流行病。傳統的技術方式具有侵入性和低效率,不衛生且不具連接性。必須有更好的方法。
Enter SOBRsafe. Our advanced transdermal (touch-based) technology detects and instantaneously reports the presence of alcohol as emitted through a user's skin - no breath, blood or urine sample is required. With a powerful backend data platform, SOBRsafe provides next generation, passive detection technology for the behavioral health, judicial and consumer markets, and for licensing and integration.
SOBRsafe即應運而生。我們先進的經皮(觸摸)技術能夠檢測並即時報告用戶通過皮膚散發出的酒精濃度——無需呼氣、血液或尿液檢測。通過強大的後端數據平台,SOBRsafe爲行爲健康、司法和消費市場提供下一代被動式檢測技術,以及用於許可和集成的技術。
The SOBRsafe technology is commercially available for point-of-care screening (SOBRcheck) and continuous monitoring (SOBRsure). At SOBRsafe, we are creating a culture of prevention and support. To learn more, visit .
SOBRsafe技術可以用於衛生點篩查(SOBRcheck)和持續監測(SOBRsure)。在SOBRsafe,我們正在創造一種預防和支持的文化。了解更多信息,請訪問。
Contact SOBRsafe:
IR@sobrsafe.com
聯繫SOBRsafe:
IR@sobrsafe.com
Safe Harbor Statement
Safe Harbor聲明
This announcement includes forward-looking statements within the meaning of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements are based on management's beliefs and assumptions, and on information currently available to management. Forward-looking statements include the information concerning our possible or assumed future results of operations set forth under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations." Forward-looking statements also include statements in which words such as "expect," "anticipate," "intend," "plan," "believe," "estimate," "consider," or similar expressions are used.
此公告包含根據《1934年證券交易法》("交易法")修正案提供的前瞻性陳述。這些陳述基於管理層的信念和假設,以及目前管理層掌握的信息。前瞻性陳述包括有關我們可能或假設的未來運營結果的信息,在"管理層的財務狀況和運營結果的分析討論"一欄下進行了闡述。"
Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties, and assumptions. Our future results and shareholder values may differ materially from those expressed in these forward-looking statements. Readers are cautioned not to put undue reliance on any forward-looking statements.
前瞻性陳述並不代表未來業績的保證。它們涉及風險、不確定性和假設。我們未來的業績和股東價值可能與這些前瞻性陳述所表達的不同。讀者被警告不要對任何前瞻性陳述過度依賴。
SOURCE: SOBR Safe, Inc.
來源: SOBR安全公司。